NGL Fine-Chem

Price chart

Previous close

₹2,878.10

Open

₹2,959.80

Day high

₹3,000.00

Day low

₹2,845.00

Listed on NSE since 8 July 2022.

Market value

₹1,778.10 Cr

P/E (trailing)

31.08

EPS (trailing)

₹92.59

Price to book

5.40

Dividend yield

0.06%

Debt to equity

0.37

Profit margin

10.7%

Beta

0.90

Volume today

8,704

Average volume

12,200

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: NGL Fine-Chem’s results filed with NSE, consolidated (the whole group). Net profit is the share of NGL Fine-Chem’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: NGL Fine-Chem’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

NGL Fine-Chem Limited develops and manufactures veterinary APIs, human APIs, intermediates, and finished dosage forms in India, Europe, the Asia Pacific, the United States, and internationally. The company offers afoxolaner, amitraz, atovaquone, buparvaquone, butaphosphan, carprofen, clorsulon, closantel base, closantel sodium, decoquinate, diminazene diaceturate, febantel, fenbendazole, fluazuron, flumethrin, flunixin meglumine, fluralaner, halquinol, homidium chloride, imidocarb dipropionate, isometamidium chlroide HCl, lotilaner, marbofloxacin, maropitant citrate monohydrate, nitroscanate, nitroxynil, oclacitinib maleate, oxfendazole, parvaquone, permethrin, phenazone, ponazuril, praziquantel, ractopamine HCL, rafoxanide, ricobendazole, r-praziquantel, sarolaner, s-methoprene, toldimfos sodium, toltrazuril, triclabendazole, xylazine base, xylazine HCl, and zilpaterol. It also provides anthelmintics, antiprotozoals, ectoparasiticides, phosphorus supplements, coccidiostats, and non-steroidal anti-inflammatory drugs. In addition, the company offers atovaquone, nitazoxanide, and praziquantel for anti malarial, anti diarrheal, and anthelmintic therapeutic categories. Further, it provides specialty chemicals, such as meglumine, n-ethyl-d-glucamine, n-octyl-d-glucamine, 1,4,7-trimethyl-1,4,7-triazonane, and Mn-MeTACN. It serves companies engages in manufacturing custom pharmaceuticals. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.

Industry

Drug Manufacturers - General

Based in

Mumbai

Employees

498

Company website · Profile: Yahoo Finance

No headlines name NGL Fine-Chem in the last day or two.

• Dividend - Rs 1.75 Per Share

  Dividend · ex-date 18 August 2026

• Dividend - Rs 1.75 Per Share

  Dividend · ex-date 12 August 2025

• Annual General Meeting/Dividend - Rs 1.75 Per Share

  Dividend · ex-date 16 August 2024

• Annual General Meeting/Dividend - Rs 1.75 Per Share

  Dividend · ex-date 18 August 2023

Source: NSE. Latest first.